Skip to main content

Table 2 The clinicopathological features of patients with DLBCL

From: MiR-214 prevents the progression of diffuse large B-cell lymphoma by targeting PD-L1

CharacteristicTotal number of patientsExpression of miR-214P value
 15High (N = 7)aLow (N = 8) 
Age (years)   0.447
  ≥ 558 (53.33%)35 
 < 557 (46.67%)43 
Gender   0.833
 Male9 (60.00%)45 
 Female6 (40.00%)33 
Tumor size (cm)   0.020
  ≥ 39 (60.00%)27 
 < 36 (40.00%)51 
Clinical stage   0.036
 I - II5 (33.33%)41 
 III - IV10 (66.67%)27 
bLDH   0.782
 High (≥ 300)8 (53.33%)44 
 Low (<  300)7 (46.67%)34 
cIPI   0.013
 Low (0–2)4 (26.67%)40 
 High (≥ 3)11 (73.33%)38 
  1. aThe median of relative miR-214 expression level is 2.53, so the number of low miR-214 expression is 8 (< 2.53). bLDH: Lactate dehydrogenase; c IPI: International prognostic index